SolarisRTC Europe: From Vision to Reality On June 11, 2025, SolarisRTC officially became established in Europe. Today, a little over three months later, I pause with gratitude. I am thankful for the many experts I have been working with those who shared knowledge, perspective, and trust to make this step possible. And I am proud of […]
How AI & Digital Pathology Should be Advancing Rare Cancer Diagnosis
Precision tools for complex oncology challenges Picking up where we left off (see Accelerating Rare Disease Diagnosis): our digital pathology journey continues, this time focused on rare cancers. These are often underrepresented, underdiagnosed, and underserved, despite their significant burden. Globally, rare cancers account for approximately 26.7% of all new cancer cases and 30% of cancer related deaths (GLOBOCAN 2022). In […]
The Role of AI in Accelerating Rare Disease Diagnosis
AI in rare disease diagnosis: Advancing Precision and Timely Access with Digital Pathology When talking with a friend about rare cancers and how the system is not serving those patients, I thought, not only do we have rare cancers, we have many rare diseases. So, I started my research: “Over 300 million people worldwide live with […]
Embracing Growth Through Authenticity
As I reflect on the journey travelled and worked on so far, I am profoundly grateful for the challenges and struggles that have shaped me. When I shared this with a friend, this image was created for me. It inspired me to blog about it from my and my company’s perspective. At SolarisRTC, our commitment […]
Reflecting on a Year of Gratitude: Serving Clients, Advancing Healthcare
We all are patients As the year wraps up, I’m deeply grateful for the privilege of collaborating with my clients. Every project I’ve undertaken, every solution we’ve crafted together, has been a step forward—not just for their growth, but for the betterment of healthcare as a whole. Helping my clients develop and excel in their domains […]
The Urgent Need for Global Collaboration in Health Care
In this digital era, where we have so many emerging products and technological advancements which are creating opportunities we never experienced before, it’s saddening to observe gaps in global health care. One of them is disparity in the provision of diagnosis and treatment of diseases such as cervical cancer across the globe. In certain parts […]
Moving from Boston to Silver Spring: A Journey of Dedication and Devotion
Moving from Boston to Silver Spring: A Journey of Dedication and Devotion Even though I truly enjoyed living in Boston, it was time for a move. It was time to move closer to the heart of what matters most. Patients matter. Good care matters. Everyone has the right to be taken care of. The decisions […]
No more side effects
No more side effects A quick search with key words “side effect definition” resulted in a list with multiple definitions, of which I picked the three (3) references Google displayed at the top: NCI dictionary of cancer terms* “An effect of a drug or other type of treatment that is in addition to or beyond […]
One size does not fit all
One size does not fit all As many of you, I was participating in the annual American Society of Clinical Oncology (ASCO) event. It always impresses me the amount of individuals participating in this event and working in this space. I am grateful to be one of them, to be a cog in this continuum […]
Science talks. Collaborative partnerships make it happen.
Science talks. Collaborative partnerships make it happen. The LDT rule. It is here, it has been announced. There are many comments, blogs, websites, articles, webinars, panel sessions and posts published about it and it affects many. Therefore, I am grateful to notice that all affected stakeholders, have been, are and keep partnering in development of […]